Insider Transactions Reported by 24 Insiders of Trevi Therapeutics, Inc.

Symbol
TRVI on Nasdaq
Location
New Haven, CT

Insiders trading volume in the past year

Trevi Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ali Behbahani 10%+ Owner $16,814,393 31 Dec 2025
Paul Edward Walker 10%+ Owner $16,814,393 31 Dec 2025
Scott D. Sandell 10%+ Owner $16,814,393 31 Dec 2025
Forest Baskett 10%+ Owner $16,814,393 31 Dec 2025
New Enterprise Associates 16, L.P. 10%+ Owner $16,814,393 31 Dec 2025
Carmen Chang 10%+ Owner $16,814,393 31 Dec 2025
Mohamad Makhzoumi 10%+ Owner $16,814,393 31 Dec 2025
Anthony A. Florence Jr. 10%+ Owner $16,814,393 31 Dec 2025
TPG GP A, LLC Former 10% Owner $7,726,264 01 Jul 2022
Peter W. Sonsini 10%+ Owner $1,916,875 11 Apr 2022
Thomas Sciascia Chief Scientific Officer $1,461,062 -$17,365 -1.2% 19 Feb 2026
Jennifer L. Good President & CEO, Director $1,403,365 -$34,625 -2.4% 19 Feb 2026
David P. Meeker Director $1,033,286 11 Jun 2025
Farrell Simon Chief Commercial Officer $549,820 19 Feb 2026
Lisa Delfini Chief Financial Officer $33,041 31 May 2025
Christopher Galletta Controller and Principal Accounting Officer $13,334 19 Feb 2026
David C. Hastings Chief Financial Officer 08 Jan 2026
Michael Thomas Heffernan Director 11 Jun 2025
Anne Vanlent Director 11 Jun 2025
Dominick Colangelo Director 11 Jun 2025
William P. Forbes Chief Development Officer 29 Jun 2022
James Cassella V Chief Development Officer 19 Feb 2026
David J. Clark Chief Medical Officer 15 Feb 2024
Mathers Edward T. Director 11 Jun 2025

Recent Insider Transactions by Companies or Individuals for Trevi Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
James Cassella V TRVI Stock Option (right to buy) Award 215,000 215,000 19 Feb 2026 Direct
Christopher Galletta TRVI Stock Option (right to buy) Award 35,000 35,000 19 Feb 2026 Direct
Thomas Sciascia TRVI Stock Option (right to buy) Award 85,000 85,000 19 Feb 2026 Direct
Jennifer L. Good TRVI Stock Option (right to buy) Award 675,000 675,000 19 Feb 2026 Direct
Farrell Simon TRVI Stock Option (right to buy) Award 160,000 160,000 19 Feb 2026 Direct
David C. Hastings TRVI Stock Option (right to buy) Award 375,000 375,000 08 Jan 2026 Direct
Christopher Galletta TRVI Common Stock Options Exercise 19.3% 4,225 26,095 02 Dec 2025 Direct
Christopher Galletta TRVI Stock Option (right to buy) Options Exercise -21.1% -4,225 15,775 02 Dec 2025 Direct
Mathers Edward T. TRVI Nonstatutory Stock Option (right to buy) Award 45,000 45,000 11 Jun 2025 Direct
Dominick Colangelo TRVI Nonstatutory Stock Option (right to buy) Award 45,000 45,000 11 Jun 2025 Direct
Michael Thomas Heffernan TRVI Nonstatutory Stock Option (right to buy) Award 45,000 45,000 11 Jun 2025 Direct
Anne Vanlent TRVI Nonstatutory Stock Option (right to buy) Award 45,000 45,000 11 Jun 2025 Direct
David P. Meeker TRVI Nonstatutory Stock Option (right to buy) Award 45,000 45,000 11 Jun 2025 Direct
Christopher Galletta TRVI Performance Stock Option (right to buy) Award 187.5% 8,550 13,110 31 May 2025 Direct
Thomas Sciascia TRVI Performance Stock Option (right to buy) Award 187.5% 60,000 92,000 31 May 2025 Direct
Lisa Delfini TRVI Performance Stock Option (right to buy) Award 187.5% 72,000 110,400 31 May 2025 Direct
Farrell Simon TRVI Performance Stock Option (right to buy) Award 187.5% 72,000 110,400 31 May 2025 Direct
Jennifer L. Good TRVI Performance Stock Option (right to buy) Award 187.5% 102,000 156,400 31 May 2025 Direct
Scott D. Sandell TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Scott D. Sandell TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
Anthony A. Florence Jr. TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Anthony A. Florence Jr. TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
Ali Behbahani TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Ali Behbahani TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
Forest Baskett TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Forest Baskett TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
Mohamad Makhzoumi TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Mohamad Makhzoumi TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
Paul Edward Walker TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Paul Edward Walker TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
New Enterprise Associates 16, L.P. TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 Direct
New Enterprise Associates 16, L.P. TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 Direct
Carmen Chang TRVI Common Stock Exercise of in-the-money or at-the-money derivative security 17.8% 1,851,852 12,273,280 17 Apr 2025 See Note 1
Carmen Chang TRVI 3.5-Year Common Stock Warrant Exercise of in-the-money or at-the-money derivative security -100% -1,851,852 0 17 Apr 2025 See Note 1
Thomas Sciascia TRVI Common Stock Sale -1.17% $17,365 $6.60 -2,631 221,373 25 Mar 2025 Direct
Thomas Sciascia TRVI Common Stock Options Exercise 1.19% 2,631 224,004 25 Mar 2025 Direct
Thomas Sciascia TRVI Stock Option (right to buy) Options Exercise -100% -2,631 0 25 Mar 2025 Direct
Jennifer L. Good TRVI Common Stock Sale -2.41% $34,625 $6.58 -5,263 213,313 21 Mar 2025 Direct
Jennifer L. Good TRVI Common Stock Options Exercise 2.47% 5,263 218,576 21 Mar 2025 Direct
Jennifer L. Good TRVI Stock Option (right to buy) Options Exercise -100% -5,263 0 21 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.